Pharmaceutical issues of paclitaxel. Preclinical pharmacology and phase I clinical trials.
Burris
H A
HA
Institute for Drug Development, San Antonio, TX.
D000818:Animals; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D017321:Clinical Trials, Phase I as Topic; D004342:Drug Hypersensitivity / Q000209:etiology; D004354:Drug Screening Assays, Antitumor; D006801:Humans; D009369:Neoplasms / Q000188:drug therapy; D009503:Neutropenia / Q000139:chemically induced; D017239:Paclitaxel / Q000009:adverse effects / Q000494:pharmacology / Q000627:therapeutic use*
D017239:Paclitaxel